Kwong Yet Lung Company FDA Inspection Record

FEI 3000719305 · Inspections, Form 483s, warning letters and import refusals

Kwong Yet Lung Company is an FDA-inspected facility (FEI 3000719305) located in Las Vegas, NV, US. RegDataLab tracks 6 FDA inspections and 1 compliance action at this facility.

Reviewing Kwong Yet Lung Company as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Kwong Yet Lung Company yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Apr 25, 2025: No Action Indicated (NAI)
Inspections on record
6 (1 OAI, 3 VAI, 2 NAI)
Last OAI inspection
May 7, 2014
Warning letters
1 listed by FDA for this FEI, latest Sep 10, 2014

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 25, 2025No Action Indicated (NAI)No citations listed
Nov 30, 2017Voluntary Action Indicated (VAI)Sanitation monitoring (21 CFR 123.11(b))
Storage and Distribution (21 CFR 117.93)
Verification - record review - frequency (21 CFR 123.8(a)(3))
Records system (21 CFR 123.6(c)(7))
and 2 more
Apr 1, 2016Voluntary Action Indicated (VAI)Sanitation monitoring (21 CFR 123.11(b))
Monitoring - adequacy (21 CFR 123.6(c)(4))
Verification - record review - frequency (21 CFR 123.8(a)(3))
Verification procedures - none/frequency (21 CFR 123.6(c)(6))
and 3 more
May 7, 2014Official Action Indicated (OAI)Sanitation monitoring (21 CFR 123.11(b))
Monitoring - adequacy (21 CFR 123.6(c)(4))
No HACCP plan (21 CFR 123.6(b))
HACCP plan implementation (21 CFR 123.6(b))
and 2 more
May 20, 2011Voluntary Action Indicated (VAI)No citations listed
Sep 1, 2010No Action Indicated (NAI)No citations listed

Facility details

Company
Kwong Yet Lung Company
Location
Las Vegas, NV (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.